About this trial

Anastomotic leakage (AL) is a severe complication after colorectal surgery, with incidence rates of 2-30%. This prospective, single-center observational cohort study aims to identify and quantify independent risk factors for AL, determine its incidence and impact on outcomes, and develop a predictive model. Approximately 430 patients undergoing colorectal resection with anastomosis will be enrolled from August 2025 to August 2026. Risk factors will be assessed preoperatively, intraoperatively, and postoperatively. AL will be defined and graded per the International Study Group of Rectal Cancer (ISGRC) criteria.

Eligibility criteria

Qualifiers

Aged ≥18 years

Undergoing elective or emergency colorectal resection with primary anastomosis (e.g., ileocolic, colocolic, colorectal, coloanal)

Providing written informed consent

Disqualifiers

Colorectal resection without anastomosis (e.g., end stoma)

Inflammatory bowel disease (Crohn's, ulcerative colitis)

History of previous colorectal surgery involving anastomosis

Pregnancy

Trial design

Treatments tested in this trial

  • Patients Undergoing Colorectal Resection with Anastomosis

Treatment groups

430 Participants
are divided into 1 treatment group

Locations

1
Minia University Hospital61519, MinyaMinya Governorate, Egypt

Sponsors and collaborators

Minia University

Lead sponsor